October 28, 2025

In an interview with Pharmaceutical Commerce, Jen Butler, CCO of Pleio, noted that while DTC drug models expand access, they often leave patients without the guidance and connection needed for safe, consistent use. She emphasized that true adherence requires pairing digital convenience with human conversation and clinical oversight.

October 1, 2025

Pleio CEO Michael Oleksiw appears on Planetary Health First, Mars Next to explore how tackling loneliness is key to better health outcomes. He reveals how Pleio’s human-first approach helps patients stay on therapy by addressing emotional barriers that technology alone can’t solve.

September 24, 2025

As part of Fierce Pharma Marketing’s Rising Stars series, Pleio Marketing Manager Madison Norman discusses why empathy should lead the way in health tech. She explores how balancing innovation with human understanding can drive more meaningful patient experiences.

WE PUT PRIVACY FIRST. GOODSTART® IS A FULLY TESTED, HIGHLY RELIABLE, TCPA, SOC 2 TYPE 2 CERTIFIED, AND HIPAA COMPLIANT MEDICATION SUPPORT PROGRAM.

Patient data is strictly used to support patients to take medications as prescribed by their healthcare professional.

CONTACT   |   PRIVACY   |   SUPPLIER CONDUCT   |  CAREERS



© 2025 Pleio, Inc All rights reserved.